🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 14 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/05/1979 | 1,70 | 1,74 | 1,69 | 1,73 | +1,95% | 2,74% | 1.324.253 |
| 10/05/1979 | 1,72 | 1,72 | 1,70 | 1,70 | -2,29% | 1,54% | 3.263.472 |
| 09/05/1979 | 1,76 | 1,76 | 1,73 | 1,74 | -1,13% | 1,51% | 2.112.768 |
| 08/05/1979 | 1,73 | 1,77 | 1,72 | 1,76 | +1,34% | 2,48% | 2.761.690 |
| 07/05/1979 | 1,76 | 1,76 | 1,73 | 1,73 | -2,06% | 1,51% | 2.199.542 |
| 04/05/1979 | 1,79 | 1,80 | 1,77 | 1,77 | -1,29% | 1,67% | 1.237.478 |
| 03/05/1979 | 1,80 | 1,81 | 1,79 | 1,79 | -0,37% | 0,92% | 2.067.494 |
| 02/05/1979 | 1,81 | 1,81 | 1,80 | 1,80 | -0,91% | 0,92% | 2.897.510 |
| 01/05/1979 | 1,82 | 1,82 | 1,81 | 1,82 | +0,00% | 0,73% | 4.119.898 |
| 30/04/1979 | 1,80 | 1,83 | 1,80 | 1,82 | +0,92% | 1,66% | 3.769.027 |
| 27/04/1979 | 1,78 | 1,81 | 1,78 | 1,80 | +1,31% | 1,67% | 2.542.867 |
| 26/04/1979 | 1,76 | 1,78 | 1,74 | 1,78 | +0,94% | 2,26% | 1.852.445 |
| 25/04/1979 | 1,75 | 1,76 | 1,74 | 1,76 | +0,76% | 1,33% | 1.709.078 |
| 24/04/1979 | 1,73 | 1,75 | 1,73 | 1,75 | +0,96% | 1,15% | 5.474.333 |
| 23/04/1979 | 1,74 | 1,74 | 1,71 | 1,73 | -1,14% | 1,34% | 8.734.032 |
| 20/04/1979 | 1,76 | 1,76 | 1,73 | 1,75 | -0,75% | 1,32% | 1.814.717 |
| 19/04/1979 | 1,76 | 1,76 | 1,74 | 1,76 | +0,38% | 1,13% | 1.633.622 |
| 18/04/1979 | 1,74 | 1,76 | 1,73 | 1,76 | +1,15% | 1,34% | 3.603.024 |
| 17/04/1979 | 1,73 | 1,74 | 1,73 | 1,74 | +0,57% | 0,76% | 1.739.261 |
| 16/04/1979 | 1,73 | 1,73 | 1,71 | 1,73 | -0,57% | 0,96% | 1.618.531 |
| 12/04/1979 | 1,76 | 1,76 | 1,74 | 1,74 | -1,13% | 1,51% | 1.497.802 |
| 11/04/1979 | 1,79 | 1,79 | 1,76 | 1,76 | -1,67% | 1,67% | 1.810.944 |
| 10/04/1979 | 1,77 | 1,79 | 1,77 | 1,79 | +0,74% | 0,94% | 2.365.546 |
| 09/04/1979 | 1,78 | 1,78 | 1,75 | 1,77 | -0,19% | 1,49% | 1.456.301 |
| 06/04/1979 | 1,77 | 1,79 | 1,77 | 1,78 | +0,38% | 0,94% | 2.071.267 |
| 05/04/1979 | 1,78 | 1,78 | 1,77 | 1,77 | -0,75% | 0,75% | 1.803.398 |
| 04/04/1979 | 1,78 | 1,80 | 1,78 | 1,78 | +1,32% | 1,31% | 2.418.365 |
| 03/04/1979 | 1,74 | 1,78 | 1,74 | 1,76 | +1,53% | 2,29% | 1.169.568 |
| 02/04/1979 | 1,75 | 1,75 | 1,72 | 1,73 | -0,95% | 1,90% | 928.109 |
| 30/03/1979 | 1,74 | 1,76 | 1,74 | 1,75 | +0,38% | 1,14% | 1.007.338 |